facebook-page-view
Advertisement

Biocon Biologics

Biocon Biologics appoints new MD, CEO

Healthcare

Biocon Biologics appoints new MD, CEO

Biocon Biologics on Monday said it has appointed Shreehas Tambe as managing director and chief executive officer of the company. ......

Premium
Analysis: M&A deal value in healthcare and pharma hits record high in Jan-June

Healthcare

Analysis: M&A deal value in healthcare and pharma hits record high in Jan-June

Merger and acquisitions (M&As) deal value in the healthcare and pharmaceutical space hit a record high in Jan-June, crossing the ......

Kiran Mazumdar-Shaw co-founded biotech startup raises Series A funding

Healthcare

Kiran Mazumdar-Shaw co-founded biotech startup raises Series A funding

Immuneel Therapeutics Pvt Ltd, co-founded by Biocon founder Kiran Mazumdar-Shaw, has raised around $15 million (Rs 116 crore) in a ......

PE-backed Biocon Biologics to offer 15% stake to Serum Institute unit

Healthcare

PE-backed Biocon Biologics to offer 15% stake to Serum Institute unit

Biocon Biologics, a unit of drugmaker Biocon Ltd, said late on Thursday it would offer a stake of about 15% ......

Premium
Jan Deals Wrap: Adani, Udaan, OmniActive rock the charts

Finance

Jan Deals Wrap: Adani, Udaan, OmniActive rock the charts

The first month of the new year, which continues to be affected by coronavirus just like 2020, saw a string ......

Grapevine: New financial reporting norms likely; Goldman Sachs to buy stake in Biocon unit

General

Grapevine: New financial reporting norms likely; Goldman Sachs to buy stake in Biocon unit

The ministry of corporate affairs may ask large unlisted firms to file financial statements more frequently with the Registrar of ......

Grapevine: Tiger Global closes mega fund, likely to lead Dream11 funding

General

Grapevine: Tiger Global closes mega fund, likely to lead Dream11 funding

New York-based Tiger Global Management has closed a $3.75 billion (about Rs 26,800 crore at current exchange rate) global private ......

True North to invest $75 mn in Biocon's biosimilar unit

Healthcare

True North to invest $75 mn in Biocon's biosimilar unit

Indian biotechnology firm Biocon Ltd on Monday said that private equity firm True North will invest Rs 536.25 crore ($74.84 ......

Biocon buys Pfizer's R&D facility to boost biosimilars development

Healthcare

Biocon buys Pfizer's R&D facility to boost biosimilars development

Indian biotechnology firm Biocon Ltd on Tuesday said it has acquired a Chennai-based research and development (R&D) facility from Pfizer ......